Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04732325 · ClinicalTrials.gov registry record · NA

Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain

A NA study, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT04732325: Completed NA study, sponsored by University of Michigan.

NCT04732325 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04732325, a NA study, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

Doctors sometimes treat chronic pain with devices that send mild electrical currents into the spinal cord. This type of treatment is referred to as neurostimulation. A common form of neurostimulation therapy is spinal cord stimulation (SCS). In this study, how SCS affects pain processing and relieves pain will be studied. Multiple forms of SCS will be examined in chronic pain patients who are receiving SCS from their own doctors as part of their standard of care. During the study, participants will be asked to complete a variety of evaluations at certain time points.

Primary Outcome

TS refers to an increased perception of pain in response to sequential stimuli of equal physical strength. At the end of each treatment period, TS scores were calculated by subtracting the average pain rating of the single-stimulus trials from the average pain rating of the ten-stimuli trials. If the difference is a positive number, the researchers will conclude that there was pain summation, where larger numbers will indicate increased pain summation or TS. If the difference is zero or a negati

Interventions

  • DEVICE Spinal cord stimulation

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2021-09-11
Est. Completion 2024-06-18
Phase NA
University of Michigan

1,327 total trials

What the finished NCT04732325 record still lists

NCT04732325 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Spinal cord stimulation is the first listed.

NCT04732325 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04732325 about?

NCT04732325 is a clinical study titled "Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain". Doctors sometimes treat chronic pain with devices that send mild electrical currents into the spinal cord. This type of treatment is referred to as neurostimulation. A common form of neurostimulation therapy is spinal cord stimulation (SCS). In this study, how SCS affects pain processing and relieve...

What is the current status of trial NCT04732325?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2021-09-11. Estimated completion is 2024-06-18.

What interventions are being tested in trial NCT04732325?

The interventions under investigation include: Spinal cord stimulation (DEVICE).

Who is sponsoring clinical trial NCT04732325?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04732325's enrollment target sits among peer trials

34 1570th of 2000 higher than 427 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04732325, the US trial registry maintained by the National Library of Medicine. NCT04732325 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.